Erythropoiesis-stimulating agents (ESAs) increase hemoglobin levels, reduce transfusion
requirements, and have been the standard of treatment for anemia in patients with chronic …

Iron status is the result of the balance between the rate of erythropoiesis and the amount of
the iron stores. Direct consequence of an imbalance between the erythroid marrow iron …

Background/purpose Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase
inhibitor, promotes erythropoiesis and regulates iron metabolism. This study investigated the …

Abstract Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in
patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially …

Background We aimed to identify associations between erythroferrone (ERFE), a regulator
of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to …

Darah yang mengalir dalam tubuh mempunyai kemampuan untuk dideteksi dengan
bantuan citra. Fungsi utama dari darah, khususnya sel darah merah, yang dikenal sebagai …

Kidney disease is associated with a wide variety of metabolic abnormalities that accompany
the uremic state and the state of dialysis dependence. These include altered L-carnitine …

Background Whether serum apolipoprotein B (ApoB) is a risk factor for the development of
Chronic kidney disease (CKD) has not been fully established in the general population …

Background: The prevalence of chronic kidney failure in Australia, Japan and Europe is 6-
11%, increased relatively about 5-8% per year. Meanwhile, in Indonesia, the prevalence of …

Background: To observe the efficacy and safety of roxadustat, an inhibitor of proline
hydroxylase, in renal allograft anemia patients. Methods: This prospective study collected …